Dechra is a finished-dose manufacturer. It appears in 322 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with DKMA (DK), MPA (SE) and URPL (PL).
| Regulator | Filings | GMP certificates |
|---|---|---|
| DKMA (DK) | 125 | None |
| MPA (SE) | 75 | None |
| URPL (PL) | 71 | None |
| Health Canada | 43 | None |
| EMA | 7 | None |
| BFARM (DE) | 1 | None |
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Choose your molecules and target markets. Dechra comes back tiered against every other supplier able to file there.
Start for free